+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Primaquine"

From
From
From
From
Primaquine (CAS 90-34-6) Global Market Research Report 2024 - Product Thumbnail Image

Primaquine (CAS 90-34-6) Global Market Research Report 2024

  • Report
  • March 2024
  • 50 Pages
  • Global
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Primaquine is an antimalarial drug used to treat and prevent malaria caused by Plasmodium vivax and Plasmodium ovale. It is also used to treat infections caused by other protozoal parasites, such as Babesia microti and Toxoplasma gondii. Primaquine is a member of the 8-aminoquinoline class of drugs, which are known for their ability to inhibit the growth of malaria parasites. Primaquine is available in both oral and intravenous formulations, and is typically used in combination with other antimalarial drugs. The Primaquine market is a rapidly growing segment of the Infectious Diseases Drugs market. Primaquine is increasingly being used to treat and prevent malaria in both endemic and non-endemic regions. The drug is also being used to treat other protozoal infections, such as Babesia microti and Toxoplasma gondii. Companies in the Primaquine market include GlaxoSmithKline, Sanofi, Novartis, Pfizer, Merck, and Bayer. Show Less Read more